CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: NOP58 (ImmuneEditome ID:51602)

1. Gene summary of enriched editing regions for NOP58

check button Gene summary
Gene informationGene symbol

NOP58

Gene ID

51602

GeneSynonymsHSPC120|NOP5|NOP5/NOP58
GeneCytomap

2q33.1

GeneTypeprotein-coding
GeneDescriptionnucleolar protein 58|NOP58 ribonucleoprotein homolog|nucleolar protein 5|nucleolar protein NOP5/NOP58
GeneModificationdate20230409
UniprotIDQ9Y2X3;H7BZ72;F8WED0
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr2:202279595-202280278:+ENST00000467734.4ENSG00000055044.9NOP58ncRNA_intronicL2a,FLAM_C,AluSxchr2:202279595-202280278:+.alignment
chr2:202279595-202280278:+ENST00000472050.4ENSG00000055044.9NOP58ncRNA_intronicL2a,FLAM_C,AluSxchr2:202279595-202280278:+.alignment
chr2:202279595-202280278:+ENST00000478941.1ENSG00000055044.9NOP58ncRNA_intronicL2a,FLAM_C,AluSxchr2:202279595-202280278:+.alignment
chr2:202279595-202280278:+ENST00000488403.4ENSG00000055044.9NOP58ncRNA_intronicL2a,FLAM_C,AluSxchr2:202279595-202280278:+.alignment
chr2:202279595-202280278:+ENST00000492688.4ENSG00000055044.9NOP58ncRNA_intronicL2a,FLAM_C,AluSxchr2:202279595-202280278:+.alignment
chr2:202285896-202290104:+ENST00000264279.8ENSG00000055044.9NOP58exonicAluYc,Tigger9a,AluY,AluSp,Tigger4b,AluSx3,AluSx,MER20,AluSq2,AluSx4,L1MB4chr2:202285896-202290104:+.alignment
chr2:202285896-202290104:+ENST00000433543.2ENSG00000055044.9NOP58exonicAluYc,Tigger9a,AluY,AluSp,Tigger4b,AluSx3,AluSx,MER20,AluSq2,AluSx4,L1MB4chr2:202285896-202290104:+.alignment
chr2:202294120-202294934:+ENST00000264279.8ENSG00000055044.9NOP58intronicAluSg7,MER44B,AluSq2chr2:202294120-202294934:+.alignment
chr2:202294120-202294934:+ENST00000433543.2ENSG00000055044.9NOP58intronicAluSg7,MER44B,AluSq2chr2:202294120-202294934:+.alignment
chr2:202298346-202299268:+ENST00000264279.8ENSG00000055044.9NOP58intronicL1ME4c,AluSc5,AluSqchr2:202298346-202299268:+.alignment


Top

2. Tumor-specific enriched editing regions for NOP58


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
chr2:202298346-202299268:+THCAEER3.1787e-02image
ENSG00000055044.9,NOP58THCAEAG3.1787e-02image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
chr2:202298346-202299268:+COADPathEER3.1271e-028.4045e-030.1823image
ENSG00000055044.9,NOP58COADPathEAG1.9980e-025.0409e-030.1920image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for NOP58


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

4. Enriched editing regions and immune related splicing for NOP58


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
ENSG00000055044.9,NOP58
TGCTEAGESENSG00000050748.13chr5180269279:180269409:180279795:180280036:180280439:180280581-0.34716.5591e-031.3679e-05-0.4087imageNOP58ACIN1;ADAR;AIFM1;ALYREF;AUH;BCCIP;BUD13;CBX7;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FKBP4;FMR1;FTO;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP4B;LIN28;LIN28A;LIN28B;LSM11;MBNL2;METTL3;MOV10;MSI1;MSI2;NCBP3;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;RBM5;RNF219;RTCB;SAFB2;SF3A3;SF3B4;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF10;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;VIM;WTAP;XRN2;YTHDC1;YWHAG;ZC3H7B;ZFP36;ZNF184MAPK9B_cells_naiveGSVA_HALLMARK_P53_PATHWAY
chr2:202298346-202299268:+
TGCTEERESENSG00000050748.13chr5180269279:180269409:180279795:180280036:180280439:180280581-0.34717.4229e-031.3679e-05-0.4087imageNOP58CPSF6;EIF4A3;EWSR1;FUS;HNRNPA2B1;HNRNPL;LIN28;LIN28B;RBFOX2;U2AF2MAPK9B_cells_naiveGSVA_HALLMARK_P53_PATHWAY

More results



Top

5. Enriched editing regions and immune infiltration for NOP58


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr2:202298346-202299268:+CESCEERNeutrophils2.5051e-020.1630image
ENSG00000055044.9,NOP58CESCEAGNeutrophils2.3145e-020.1647image
ENSG00000055044.9,NOP58COADEAGT_cells_follicular_helper1.9521e-020.1693image
chr2:202279595-202280278:+ESCAEERB_cells_memory1.3470e-020.5074image
chr2:202285896-202290104:+ESCAEERT_cells_CD4_memory_activated1.4770e-020.2636image
chr2:202294120-202294934:+ESCAEERNK_cells_activated3.6292e-030.5402image
ENSG00000055044.9,NOP58ESCAEAGT_cells_CD4_memory_resting9.8352e-03-0.2378image
chr2:202298346-202299268:+GBMEERNK_cells_activated2.5945e-02-0.3118image
ENSG00000055044.9,NOP58GBMEAGNK_cells_activated2.5945e-02-0.3118image
chr2:202298346-202299268:+KIRCEERT_cells_CD4_naive3.9626e-02-0.1584image
ENSG00000055044.9,NOP58KIRCEAGT_cells_CD4_naive4.0214e-02-0.1580image
chr2:202298346-202299268:+LAMLEERT_cells_gamma_delta3.1094e-030.5386image
ENSG00000055044.9,NOP58LAMLEAGT_cells_CD4_memory_resting3.6162e-030.3123image
chr2:202298346-202299268:+LUADEERMast_cells_activated1.5353e-02-0.1526image
ENSG00000055044.9,NOP58LUADEAGMast_cells_activated5.5054e-03-0.1714image
chr2:202298346-202299268:+LUSCEERDendritic_cells_activated4.0970e-020.1201image
ENSG00000055044.9,NOP58LUSCEAGDendritic_cells_activated4.3425e-020.1187image
chr2:202285896-202290104:+OVEERB_cells_memory8.7290e-03-0.3535image
chr2:202298346-202299268:+PCPGEERMacrophages_M21.5645e-020.3034image
ENSG00000055044.9,NOP58PCPGEAGMacrophages_M21.5645e-020.3034image
chr2:202298346-202299268:+PRADEEREosinophils3.5057e-02-0.1470image
ENSG00000055044.9,NOP58PRADEAGEosinophils3.8146e-02-0.1435image
chr2:202298346-202299268:+SARCEERNeutrophils1.8056e-030.3690image
ENSG00000055044.9,NOP58SARCEAGNeutrophils1.8056e-030.3690image
chr2:202298346-202299268:+SKCMEERT_cells_regulatory_(Tregs)4.5473e-02-0.1264image
ENSG00000055044.9,NOP58SKCMEAGT_cells_regulatory_(Tregs)4.2760e-02-0.1277image
chr2:202285896-202290104:+STADEERT_cells_follicular_helper3.5225e-02-0.1863image
chr2:202294120-202294934:+STADEERMacrophages_M11.6398e-02-0.4029image
ENSG00000055044.9,NOP58STADEAGT_cells_CD4_memory_activated3.9172e-020.1414image
chr2:202298346-202299268:+TGCTEERT_cells_CD81.3541e-020.2307image
ENSG00000055044.9,NOP58TGCTEAGT_cells_CD81.3541e-020.2307image
chr2:202298346-202299268:+THYMEERMacrophages_M11.8583e-020.3318image
ENSG00000055044.9,NOP58UCECEAGMonocytes1.4782e-02-0.2787image
chr2:202298346-202299268:+UCSEERNK_cells_activated1.2821e-030.6297image
ENSG00000055044.9,NOP58UCSEAGNK_cells_activated1.2821e-030.6297image


Top

6. Enriched editing regions and immune gene sets for NOP58


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000055044.9,NOP58BLCAGSVA_HALLMARK_BILE_ACID_METABOLISMEAG1.7998e-03-0.2363image
chr2:202298346-202299268:+BLCAGSVA_HALLMARK_BILE_ACID_METABOLISMEER5.1556e-04-0.2620image
chr2:202298346-202299268:+BRCAGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEER1.2411e-02-0.1047image
ENSG00000055044.9,NOP58BRCAGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG7.7008e-030.1110image
ENSG00000055044.9,NOP58CESCGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG6.4304e-03-0.1970image
chr2:202298346-202299268:+CESCGSVA_HALLMARK_PANCREAS_BETA_CELLSEER8.1445e-03-0.1919image
ENSG00000055044.9,NOP58ESCAGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG7.1829e-030.2473image
chr2:202279595-202280278:+ESCAGSVA_HALLMARK_HYPOXIAEER6.9425e-030.5467image
chr2:202294120-202294934:+ESCAGSVA_HALLMARK_DNA_REPAIREER3.9852e-030.5356image
ENSG00000055044.9,NOP58GBMGSVA_HALLMARK_MYOGENESISEAG1.9192e-020.3270image
chr2:202298346-202299268:+GBMGSVA_HALLMARK_MYOGENESISEER1.9192e-020.3270image
chr2:202298346-202299268:+KIRCGSVA_HALLMARK_IL2_STAT5_SIGNALINGEER3.3350e-03-0.2246image
ENSG00000055044.9,NOP58KIRCGSVA_HALLMARK_IL2_STAT5_SIGNALINGEAG4.1759e-03-0.2193image
chr2:202298346-202299268:+LAMLGSVA_HALLMARK_HYPOXIAEER2.6520e-020.4189image
chr2:202298346-202299268:+LGGGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEER3.9897e-020.1652image
ENSG00000055044.9,NOP58LGGGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEAG3.9897e-020.1652image
ENSG00000055044.9,NOP58LUADGSVA_HALLMARK_PROTEIN_SECRETIONEAG8.9273e-03-0.1616image
chr2:202298346-202299268:+LUADGSVA_HALLMARK_PROTEIN_SECRETIONEER4.0855e-03-0.1803image
ENSG00000055044.9,NOP58LUSCGSVA_HALLMARK_E2F_TARGETSEAG3.2812e-020.1254image
chr2:202298346-202299268:+LUSCGSVA_HALLMARK_E2F_TARGETSEER2.9183e-020.1281image
ENSG00000055044.9,NOP58OVGSVA_HALLMARK_APOPTOSISEAG1.6746e-020.1817image
chr2:202285896-202290104:+OVGSVA_HALLMARK_HEME_METABOLISMEER9.1325e-030.3516image
chr2:202298346-202299268:+PAADGSVA_HALLMARK_NOTCH_SIGNALINGEER2.5903e-02-0.2375image
ENSG00000055044.9,NOP58PAADGSVA_HALLMARK_NOTCH_SIGNALINGEAG2.5903e-02-0.2375image
chr2:202298346-202299268:+PCPGGSVA_HALLMARK_MITOTIC_SPINDLEEER4.0602e-04-0.4321image
ENSG00000055044.9,NOP58PCPGGSVA_HALLMARK_MITOTIC_SPINDLEEAG4.0602e-04-0.4321image
chr2:202298346-202299268:+PRADGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEER2.6380e-03-0.2085image
ENSG00000055044.9,NOP58PRADGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEAG3.1699e-03-0.2032image
ENSG00000055044.9,NOP58SARCGSVA_HALLMARK_HYPOXIAEAG1.5692e-030.3736image
chr2:202298346-202299268:+SARCGSVA_HALLMARK_HYPOXIAEER1.5692e-030.3736image
chr2:202298346-202299268:+SKCMGSVA_HALLMARK_BILE_ACID_METABOLISMEER1.3790e-02-0.1553image
ENSG00000055044.9,NOP58SKCMGSVA_HALLMARK_BILE_ACID_METABOLISMEAG1.9394e-02-0.1472image
ENSG00000055044.9,NOP58STADGSVA_HALLMARK_PROTEIN_SECRETIONEAG2.3026e-050.2857image
chr2:202294120-202294934:+STADGSVA_HALLMARK_MYOGENESISEER1.6375e-020.4030image
chr2:202285896-202290104:+STADGSVA_HALLMARK_APICAL_SURFACEEER2.5388e-030.2646image
chr2:202298346-202299268:+STADGSVA_HALLMARK_ALLOGRAFT_REJECTIONEER1.0498e-020.2409image
chr2:202298346-202299268:+THYMGSVA_HALLMARK_KRAS_SIGNALING_DNEER2.1162e-040.5009image
ENSG00000055044.9,NOP58THYMGSVA_HALLMARK_KRAS_SIGNALING_DNEAG1.2846e-050.5696image
chr2:202298346-202299268:+UCECGSVA_HALLMARK_ALLOGRAFT_REJECTIONEER2.5250e-020.2655image
ENSG00000055044.9,NOP58UCECGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG3.5069e-030.3309image


Top

7. Enriched editing regions and drugs for NOP58


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000055044.9,NOP58BLCAAMG.706EAG1.6883e-03-0.2377image
chr2:202298346-202299268:+BLCAAMG.706EER2.5773e-03-0.2284image
ENSG00000055044.9,NOP58CESCGNF.2EAG1.3746e-020.1785image
chr2:202298346-202299268:+CESCGNF.2EER2.7987e-020.1599image
ENSG00000055044.9,NOP58COADABT.263EAG4.4007e-030.2058image
chr2:202298346-202299268:+COADCCT018159EER3.4799e-020.1549image
ENSG00000055044.9,NOP58ESCABortezomibEAG3.5689e-02-0.1944image
chr2:202298346-202299268:+ESCAKIN001.135EER4.6332e-02-0.2263image
chr2:202279595-202280278:+ESCABIRB.0796EER2.2687e-020.4728image
chr2:202294120-202294934:+ESCABMS.536924EER1.4306e-02-0.4659image
chr2:202298346-202299268:+GBMIPA.3EER1.7974e-020.3302image
ENSG00000055044.9,NOP58GBMIPA.3EAG1.7974e-020.3302image
ENSG00000055044.9,NOP58HNSCBMS.536924EAG9.5407e-030.2568image
chr2:202298346-202299268:+HNSCBMS.536924EER1.3478e-020.2464image
chr2:202298346-202299268:+KIRCDMOGEER4.4195e-030.2179image
ENSG00000055044.9,NOP58KIRCDMOGEAG3.9700e-030.2205image
ENSG00000055044.9,NOP58KIRPGW.441756EAG1.7901e-02-0.2563image
chr2:202298346-202299268:+KIRPGW.441756EER1.7901e-02-0.2563image
ENSG00000055044.9,NOP58LAMLAZD.0530EAG2.9640e-020.2360image
chr2:202298346-202299268:+LAMLCI.1040EER4.4648e-02-0.3823image
ENSG00000055044.9,NOP58LGGBMS.754807EAG2.1027e-020.1852image
chr2:202298346-202299268:+LGGBMS.754807EER2.1027e-020.1852image
ENSG00000055044.9,NOP58LIHCKIN001.135EAG1.6492e-020.2857image
chr2:202298346-202299268:+LIHCKIN001.135EER1.6492e-020.2857image
ENSG00000055044.9,NOP58LUADBexaroteneEAG7.7567e-03-0.1645image
chr2:202298346-202299268:+LUADBryostatin.1EER2.9684e-02-0.1370image
chr2:202298346-202299268:+LUSCMetforminEER7.1048e-04-0.1977image
ENSG00000055044.9,NOP58LUSCMetforminEAG6.3914e-04-0.1994image
ENSG00000055044.9,NOP58OVAZD6244EAG2.4368e-03-0.2290image
chr2:202298346-202299268:+OVBMS.509744EER1.5332e-03-0.2565image
chr2:202285896-202290104:+OVMetforminEER1.9055e-02-0.3182image
chr2:202298346-202299268:+PAADAxitinibEER8.0943e-04-0.3526image
ENSG00000055044.9,NOP58PAADAxitinibEAG8.0943e-04-0.3526image
ENSG00000055044.9,NOP58PCPGAZD7762EAG2.0470e-04-0.4514image
chr2:202298346-202299268:+PCPGAZD7762EER2.0470e-04-0.4514image
chr2:202298346-202299268:+PRADBX.795EER1.0098e-020.1789image
ENSG00000055044.9,NOP58PRADBX.795EAG9.9162e-030.1780image
chr2:202298346-202299268:+SARCBMS.509744EER3.7771e-04-0.4160image
ENSG00000055044.9,NOP58SARCBMS.509744EAG3.7771e-04-0.4160image
ENSG00000055044.9,NOP58SKCMElesclomolEAG1.4453e-02-0.1539image
chr2:202298346-202299268:+SKCMElesclomolEER1.5845e-02-0.1522image
chr2:202298346-202299268:+STADBryostatin.1EER3.2680e-030.2756image
chr2:202294120-202294934:+STADAZD.2281EER5.5433e-04-0.5540image
chr2:202285896-202290104:+STADAZD.0530EER6.2230e-03-0.2444image
ENSG00000055044.9,NOP58THCAAZD7762EAG2.1845e-02-0.1356image
chr2:202298346-202299268:+THCAAZD7762EER2.1845e-02-0.1356image
ENSG00000055044.9,NOP58THYMA.770041EAG2.7966e-04-0.4881image
chr2:202298346-202299268:+THYMGNF.2EER3.5929e-03-0.4043image
ENSG00000055044.9,NOP58UCECBMS.509744EAG4.8739e-04-0.3905image
chr2:202298346-202299268:+UCECBMS.509744EER2.0366e-02-0.2748image
chr2:202298346-202299268:+UCSFH535EER3.5998e-03-0.5816image
ENSG00000055044.9,NOP58UCSFH535EAG3.5998e-03-0.5816image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType